CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia
The objective of this study is to assess the safety and efficacy of anti-CD7 CAR T-cells in patients with refractory or relapsed T-lineage acute lymphoblastic leukemia (T-ALL).
Minimum level of pulmonary reserve defined as Grade ≤ 1 dyspnoea and oxygen satu... [+5]
Failure to meet any of the inclusion criteria [+8]